Sponsor
Carelon Research
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Carelon Research appears in 16 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
16 shownClinical Trial of a MEK Inhibitor for RASopathy-Associated Severe Infantile Hypertrophic Cardiomyopathy: Baby MERITNCT07817186 · lead sponsor · 2027-08-01
NOT_YET_RECRUITINGPumps for Kids, Infants, and NeonatesNCT02954497 · lead sponsor · 2018-10-22
UNKNOWNDyslipidemia of Obesity Intervention in TeensNCT02956590 · lead sponsor · 2018-05-01
COMPLETEDType 1 Teamwork: A Tool for Parents of Adolescents With Type 1 DiabetesNCT04073914 · lead sponsor · 2017-06-29
COMPLETEDPhosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart FailureNCT01910389 · lead sponsor · 2013-11-01
TERMINATEDSchizophrenia Cognition Scale DevelopmentNCT02118571 · lead sponsor · 2013-11-01
COMPLETEDSildenafil to Improve Exercise Capacity in People With Thalassemia and Pulmonary HypertensionNCT00872170 · lead sponsor · 2009-03-01
COMPLETEDAldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic FunctionNCT00094302 · lead sponsor · 2006-08-01
COMPLETEDThalassemia (Cooley's Anemia) Clinical Research Network (TCRN)NCT00000623 · lead sponsor · 2000-07-01
COMPLETEDPumps for Kids, Infants and Neonates (PumpKIN): The Jarvik 2015 Pivotal TrialNCT06348043 · collaborator · 2024-08-01
NOT_YET_RECRUITINGA Program to Reduce Inappropriate Medications Among Older Adults With Alzheimer's Disease: Implementation Phase 2NCT06368115 · collaborator · 2024-07-01
COMPLETEDAssessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combination of Tiotropium and Olodaterol on Reducing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [AIRWISE]NCT03265145 · collaborator · 2017-09-20
COMPLETEDThe Impact of Diabetes on REvascularizationNCT03085524 · collaborator · 2017-08-01
COMPLETEDNeurogenic Dysphonia/Dysphagia RegistryNCT02493491 · collaborator · 2015-06-01
TERMINATEDICS/LABA Adherence and COPD ExacerbationNCT02446041 · collaborator · 2015-05-01
COMPLETEDPhosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure: Extent of Renal DamageNCT01960153 · collaborator · 2013-10-01
WITHDRAWNSponsor roles
lead sponsor9
collaborator7
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.